Literature DB >> 4251769

Temporary Cushing's syndrome from percutaneous absorption of betamethasone 17-valerate.

J A Keipert, R Kelly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4251769     DOI： 10.5694/j.1326-5377.1971.tb87696.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  10 in total

1.  Effect on adrenal function of topically applied clobetasol propionate (Dermovate).

Authors:  C F Allenby; R A Main; R A Marsden; C G Sparkes
Journal:  Br Med J       Date:  1975-12-13

2.  Long-term treatment with 0-01% fluclorolone acetonide in children.

Authors:  W J Cunliffe
Journal:  Br Med J       Date:  1976-03-13

3.  Osteoporotic vertebral fracture caused by topical corticosteroid abuse: A case report.

Authors:  Stefano Piaserico; Dennis Linder; Francesco Messina; Mauro Alaibac
Journal:  Exp Ther Med       Date:  2019-07-30       Impact factor: 2.447

4.  Adverse effects of topical corticosteroid use.

Authors:  D A Fisher
Journal:  West J Med       Date:  1995-02

5.  Endocrine complications of topical and intralesional corticosteroid therapy.

Authors:  J A Curtis; E Cormode; B Laski; J Toole; N Howard
Journal:  Arch Dis Child       Date:  1982-03       Impact factor: 3.791

6.  Epidermal thinning: evaluation of commercial corticosteroids.

Authors:  R Wrench
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

7.  Adrenocortical response to adrenocorticotropic hormone in relation to duration of topical therapy and percutaneous absorption of hydrocortisone in children with dermatitis.

Authors:  M Turpeinen
Journal:  Eur J Pediatr       Date:  1989-08       Impact factor: 3.183

8.  Rational and ethical use of topical corticosteroids based on safety and efficacy.

Authors:  Sanjay K Rathi; Paschal D'Souza
Journal:  Indian J Dermatol       Date:  2012-07       Impact factor: 1.494

Review 9.  Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis.

Authors:  Elaine C Siegfried; Jennifer C Jaworski; Jennifer D Kaiser; Adelaide A Hebert
Journal:  BMC Pediatr       Date:  2016-06-07       Impact factor: 2.125

10.  A Nonsteroidal Novel Formulation Targeting Inflammatory and Pruritus-Related Mediators Modulates Experimental Allergic Contact Dermatitis.

Authors:  William C Gordon; Virginia García López; Surjyadipta Bhattacharjee; David Rodríguez Gil; Javier Alcover Díaz; Fernando Pineda de la Losa; Ricardo Palacios Peláez; Concha Tiana Ferrer; Gabriela Silvina Bacchini; Bokkyoo Jun; Hélène Varoqui; Nicolas G Bazan
Journal:  Dermatol Ther (Heidelb)       Date:  2018-02-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.